Design of a Phase 3, Global, Multicenter, Randomized, Placebo-controlled, Double-blind Study of Nipocalimab in Pregnancies At-risk for Severe Hemolytic Disease of the Fetus and Newborn

Yosuke Komatsu,E. J. T. (Joanne) Verweij,Eleonor Tiblad,Enrico Lopriore,Dick Oepkes, Prasheen Agarwal,Edwin Lam,Jocelyn H. Leu,Leona E. Ling, Leona E. Nelson, Victor Olusajo,Shumyla Saeed-Khawaja,May Lee Tjoa, Jie Zhou, Umair Amin, Waheeda Sirah,Kenneth J. Moise Jr

AMERICAN JOURNAL OF PERINATOLOGY（2024）

Cited 0|Views6

Key words

neonatal Fc receptor blocker,nipocalimab,hemolytic disease of the fetus and newborn,HDFN,intrauterine transfusion,red blood cell alloimmunization,safety,efficacy,study design

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined